Immunogenetics of Atherosclerosis—Link between Lipids, Immunity, and Genes
KY Chyu, PC Dimayuga, PK Shah - Current Atherosclerosis Reports, 2020 - Springer
Abstract Purpose of Review Atherosclerosis is a complex disease process with lipid as a
traditional modifiable risk factor and therapeutic target in treating atherosclerotic …
traditional modifiable risk factor and therapeutic target in treating atherosclerotic …
Familial hypercholesterolemia and cardiovascular disease in older individuals
ER Coutinho, MH Miname, VZ Rocha, MS Bittencourt… - Atherosclerosis, 2021 - Elsevier
Background and aims Familial hypercholesterolemia (FH) is characterized by high LDL-
cholesterol (LDL-C) and early atherosclerotic cardiovascular disease (ASCVD). With a lipid …
cholesterol (LDL-C) and early atherosclerotic cardiovascular disease (ASCVD). With a lipid …
血清胱抑素C 水平与女性无慢性肾脏疾病患者冠状动脉钙化的相关性探讨
符武岛， 李伟， 曾敏， 郑茵， 陈娟， 冯光球， 管频 - 临床心血管病杂志, 2019 - whuhzzs.com
目的: 探讨血清胱抑素C 及性别差异与无慢性肾脏病(CKD) 患者冠状动脉钙化(CAC) 的相关性.
方法: 评估456 例无CKD 和冠状动脉疾病的患者, 平均年龄(61±13) 岁, 其中女性191 例(42%) …
方法: 评估456 例无CKD 和冠状动脉疾病的患者, 平均年龄(61±13) 岁, 其中女性191 例(42%) …
Association between Coexisting Hypertension, Dyslipidemia, and Elevated C-Reactive Protein with Cardiovascular Disease in the Health and Retirement Study
T Karadimas, HCS Meier - University of …, 2024 - journals.publishing.umich.edu
Background: Cardiovascular disease (CVD) is the leading cause of death globally.
Hypertension and dyslipidemia are established CVD risk factors, but these diagnoses are …
Hypertension and dyslipidemia are established CVD risk factors, but these diagnoses are …
When Should Familial Hypercholesterolemia Be Suspected?: A Case of Dyslipidemia in Young Patient without Coronary Artery Disease
IS Ryou - Archives of Obesity and Metabolism, 2023 - koreascience.kr
Familial hypercholesterolemia (FH) is a genetic disease that is not well known or diagnosed
in Korea. This disease is associated with persistently high levels of low-density lipoprotein …
in Korea. This disease is associated with persistently high levels of low-density lipoprotein …
Correlation between serum cystatin C level and coronary artery calcification in women without chronic kidney disease
FU Wudao, LI Wei, Z Min, Z Yin, C Juan… - J Clin …, 2019 - lcxxgen.whuhzzs.com
Objective: To investigate the relationship between serum cystatin C and gender differences
in coronary artery calcification (CAC) in patients without chronic kidney disease (CKD) …
in coronary artery calcification (CAC) in patients without chronic kidney disease (CKD) …